EPINEPHrine Chloride Solution(Epinephrine Nasal Solution, USP)10mg/10mL (1 mg/mL)Vasoconstrictor For Topical ApplicationRx Only

Epinephrine Chloride Solution by

Drug Labeling and Warnings

Epinephrine Chloride Solution by is a Prescription medication manufactured, distributed, or labeled by BPI Labs, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

EPINEPHRINE CHLORIDE SOLUTION- epinephrine nasal solution solution 
BPI Labs, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

EPINEPHrine Chloride Solution
(Epinephrine Nasal Solution, USP)
10mg/10mL (1 mg/mL)
Vasoconstrictor For Topical Application
Rx Only

1 INDICATIONS AND USAGE

For use as a nasal decongestant. Apply locally as drops or spray, or with a sterile swab, as required.

2 DOSAGE AND ADMINISTRATION

Instructions for diluting

 To make Epinephrine Chloride SolutionEpinephrine Chloride Solution 1 mg/mLIsotonic Salt Solution
 0.5 mg/mL 1 mL 1 mL
 0.2 mg/mL 1 mL 4 mL
 0.1 mg/mL 1 mL 9 mL

Note: Do not use the solution if it is pinkish or darker than yellow or if it contains a precipitate.

3 WARNINGS AND PRECAUTIONS

Caution: Administer with caution to elderly people. Do not use if high blood pressure, heart disease, diabetes, or thyroid disease is present unless directed by a physician. If prompt relief is not obtained, consult a physician. Administer to pediatric patients under six years of age only on the advice of a physician.

4 DESCRIPTION

Each mL contains 1 mg Epinephrine as the hydrochloride, dissolved in isotonic sodium chloride solution with 0.5% chlorobutanol (chloroform derivative) as a preservative and not more than 0.05% sodium metabisulfite as an antioxidant.

EPINEPHrine nasal solution, USP must not be brought into contact with oxidizing agents.The solution is also quickly decomposed by iron salts and alkalies.

5 ADVERSE REACTIONS

To report SUSPECTED ADVERSE REACTIONS, contact BPI Labs, LLC at (727) 471-0850 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

6 HOW SUPPLIED/STORAGE AND HANDLING

Each carton contains one vial of 10 mg/10 mL (1 mg/mL)  of Epinephrine Chloride Solution (Epinephrine Nasal Solution,USP) in an amber glass vial.

NDC: 54288-123-01         10 mL Vial

This product is sterile until opened.

Keep this and all drugs out of the reach of children.

Store between 20° to 25°C (68° to 77°F). (See USP Controlled Room Temperature.) Do not refrigerate or freeze, Protect from light.

Do not use if cap seal is broken or missing.

Manufactured by:

BPI Labs, LLC

12393 Belcher Rd S, Suite 450

Largo, FL 33773

PACKAGE LABEL PRINCIPAL DISPLAY PANEL

Carton:
Epinephrine Chloride Solution
(Epinephrine Nasal Solution, USP)
10 mg/10 mL (1 mg/mL)
Vasoconstrictor for Topical Application
10 mL Vial

Carton

Label:
Epinephrine Chloride Solution
(Epinephrine Nasal Solution,USP)
10 mg/10 mL (1 mg/mL)
Vasoconstrictor for Topical Application
10 mL Vial

Label

EPINEPHRINE CHLORIDE SOLUTION 
epinephrine nasal solution solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC: 54288-123
Route of AdministrationNASAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
EPINEPHRINE HYDROCHLORIDE (UNII: WBB047OO38) (EPINEPHRINE - UNII:YKH834O4BH) EPINEPHRINE HYDROCHLORIDE1 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
ISOTONIC SODIUM CHLORIDE SOLUTION (UNII: VR5Y7PDT5W)  
SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
CHLOROBUTANOL (UNII: HM4YQM8WRC)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 54288-123-0110 mL in 1 BOX; Type 0: Not a Combination Product09/30/202004/11/2025
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other09/30/202004/11/2025
Labeler - BPI Labs, LLC (078627620)
Establishment
NameAddressID/FEIBusiness Operations
BPI Labs, LLC078627620manufacture(54288-123) , label(54288-123)

Revised: 4/2025
 

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.